NFNelson Fernández

Nelson Fernández

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nelson Fernández has a total of 97 co-authors. Here are the top co-authors by number of shared publications:

  • Asma Jabeen

    Univ Essex, Sch Life Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England

    3 shared publications
  • Patrick S. Spencer

    School of Biological Sciences, University of Essex, Colchester, United Kingdom

    3 shared publications
  • Soren Hayrabedyan

    Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria

    3 shared publications
  • Cristina V. Navarrete

    Histocompatibility and Immunogenetics Laboratory, NHS Blood and Transplant, London, United Kingdom

    2 shared publications
  • Eytan R. Barnea

    Department of Obstetrics, Gynecology & Reproductive Sciences University of Miami Miller School of Medicine Miami Florida USA

    2 shared publications
  • James McElhinney

    Centre for Membrane and Advanced Water Treatment (CMAT), Khalifa University, Abu Dhabi, United Arab Emirates; Khalifa University, Department of Biomedical Engineering, Abu Dhabi, United Arab Emirates

    2 shared publications

Latest Publications

  • Open Access

    Mucormycosis co-infection in COVID-19 patients: An update

    by Ahmed A. Ahmed, Zafar Rasheed, Ruqaih Alghsham, Ali Shariq, Thamir Alsaeed, Sami A. Althwab, Suliman Alsagaby, Abdullah S. M. Aljohani, Fahad A. Alhumaydhi, Sharifa K. Alduraibi, et al.

    Mucormycosis (MCM) is a rare fungal disorder that has recently been increased in parallel with novel COVID-19 infection. MCM with COVID-19 is extremely lethal, particularly in immunocompromised individuals. The collection of available scientific information helps in the management of this co-infection, but still, the main question on COVID-19, whether it is occasional, participatory, concurrent, or coincidental needs to be addressed. Several case reports of these co-infections have been explained as causal associations, but the direct contribution in immunocompromised individuals remains to be explored completely. This review aims to provide an update that serves as a guide for the diagnosis and treatment of MCM patients’ co-infection with COVID-19. The initial report has suggested that COVID-19 patients might be susceptible to developing invasive fungal infections by different species, including MCM as a co-infection. In spite of this, co-infection has been explored only in severe cases with common triangles: diabetes, diabetes ketoacidosis, and corticosteroids. Pathogenic mechanisms in the aggressiveness of MCM infection involves the reduction of phagocytic activity, attainable quantities of ferritin attributed with transferrin in diabetic ketoacidosis, and fungal heme oxygenase, which enhances iron absorption for its metabolism. Therefore, severe COVID-19 cases are associated with increased risk factors of invasive fungal co-infections. In addition, COVID-19 infection leads to reduction in cluster of differentiation, especially CD4+ and CD8+ T cell counts, which may be highly implicated in fungal co-infections. Thus, the progress in MCM management is dependent on a different strategy, including reduction or stopping of implicit predisposing factors, early intake of active antifungal drugs at appropriate doses, and complete elimination via surgical debridement of infected tissues.


    • 1 May 2022
      • Vol. 16  (3) , 1-3
    Open Access

    Future pandemics might be caused by bacteria and not viruses: Recent advances in medical preventive practice

    by Carla Bieg Salazar, Patrick Spencer, Kamaran Mohamad, Asma Jabeen, Waleed Al Abdulmonem, Nelson Fernandez


  • Open Access

    HLA-DR Genotyping and Mitochondrial DNA Analysis Reveal the Presence of Family Burials in a Fourth Century Romano-British Christian Cemetery

    by Canh P. Voong, Patrick S. Spencer, Cristina V. Navarrete, David Turner, Soren B. Hayrabedyan, Philip Crummy, Emma Holloway, Mike T. Wilson, Patricia R. Smith, Nelson Fernández

    In Colchester, Britain’s oldest recorded town, during the Roman period there were areas which were clearly used solely as cemeteries. One of the most significant is at Butt Road, which includes a late Roman probable Christian cemetery with an associated apparent church building that overlies and developed from a pagan inhumation cemetery. DNA was extracted from the long bones (femurs) of 29 individuals, mostly from a large complex of burials centered on two timber vaults. These were thought to comprise a number of family groupings, deduced from osteological analysis, stratigraphical and other considerations. The use of a modified version of the silica-based purification method recovered nanogram quantities of DNA/gram of bone. Two-stage amplification, incorporating primer-extension preamplification-polymerase chain reaction, permitted simultaneous amplification of both mitochondrial and nuclear DNA. Sequence-specific oligonucleotide probes yielded human leukocyte antigen (HLA)-DR typing of seven samples, with four revealing the infrequent HLA-DR10 genotype. Examination of the control region of mitochondrial DNA (mtDNA) by direct sequencing revealed polymorphisms yet to be reported in the modern population. HLA-DRB typing and mtDNA analysis affirmatively supported kinship among some, if not all, individuals in the ‘vault complex’ and demonstrate a European origin of the individuals investigated.


  • Open Access

    Measurements of heterotypic associations between cluster of differentiation CD74 and CD44 in human breast cancer-derived cells

    by Hussain Al Ssadh, Patrick S. Spencer, Waleed Alabdulmenaim, Rana Alghamdi, Inamul Hasan Madar, Jose M. Miranda-Sayago, Nelson Fernández

    Measurements of heterotypic associations between cluster of differentiation CD74 and CD44 in human breast cancer-derived cells Measurement of heterotypic associations between cluster of differentiation (CD) 74 and CD44 in human breast cancer-derived cells


  • PIF direct immune regulation: Blocks mitogen-activated PBMCs proliferation, promotes TH2/TH1 bias, independent of Ca2+

    by Eytan R. Barnea, David Kirk, Krassimira Todorova, James McElhinney, Soren Hayrabedyan, Nelson Fernández


  • Preimplantation factor (PIF*) regulates HLA-G expression at the feto-maternal interface

    by Soukaina Miya Hakam, Jain Hakam Pallavi, Tarui Sachiyo, Eytan R. Barnea, Nelson Fernandez


  • Quantified Colocalization Reveals Heterotypic Histocompatibility Class I Antigen Associations on Trophoblast Cell Membranes: Relevance for Human Pregnancy1

    by Asma Jabeen, José Maria Miranda-Sayago, Boguslaw Obara, Patrick Simon Spencer, Gill Barbara Dealtry, Soren Hayrabedyan, Valerie Shaikly, Pierre Philippe Laissue, Nelson Fernández

    Human placental syncytiotrophoblasts lack expression of most types of human leukocyte antigen (HLA) class I and class II molecules; this is thought to contribute to a successful pregnancy. However, the HLA class Ib antigens HLA-G, -E, and -F and the HLA class Ia antigen HLA-C are selectively expressed on extravillous trophoblast cells, and they are thought to play a major role in controlling feto-maternal tolerance. We have hypothesized that selective expression, coupled with the preferential physical association of pairs of HLA molecules, contribute to the function of HLA at the feto-maternal interface and the maternal recognition of the fetus. We have developed a unique analytical model that allows detection and quantification of the heterotypic physical associations of HLA class I molecules expressed on the membrane of human trophoblast choriocarcinoma cells, ACH-3P and JEG-3. Automated image analysis was used to estimate the degree of overlap of HLA molecules labeled with different fluorochromes. This approach yields an accurate measurement of the degree of colocalization. In both JEG-3 and ACH-3P cells, HLA-C, -E, and -G were detected on the cell membrane, while the expression of HLA-F was restricted to the cytoplasm. Progesterone treatment alone induced a significant increase in the expression level of the HLA-G/HLA-E association, suggesting that this heterotypic association is modulated by this hormone. Our data shows that the cell-surface HLA class I molecules HLA-G, -E, and -C colocalize with each other and have the potential to form preferential heterotypic associations.


  • Open Access

    Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform

    by Oliver Pérez, Belkis Romeu, Osmir Cabrera, Elizabeth González, Alexander Batista-Duharte, Alexis Labrada, Rocmira Pérez, Laura M. Reyes, Wendy Ramírez, Sergio Sifontes, et al.

    The development of effective vaccines against neglected diseases, especially those associated with poverty and social deprivation, is urgently needed. Modern vaccine technologies and a better understanding of the immune response have provided scientists with the tools for rational and safer design of subunit vaccines. Often, however, subunit vaccines do not elicit strong immune responses, highlighting the need to incorporate better adjuvants; this step therefore becomes a key factor for vaccine development. In this review we outline some key features of modern vaccinology that are linked with the development of better adjuvants. In line with the increased desire to obtain novel adjuvants for future vaccines, the Finlay Adjuvant Platform offers a novel approach for the development of new and effective adjuvants. The Finlay Adjuvants (AFs), AFPL (proteoliposome) and AFCo (cochleate), were initially designed for parenteral and mucosal applications, and constitute potent adjuvants for the induction of Th1 responses against several antigens. This review summarizes the status of the Finlay technology in producing promising adjuvants for unsolved-vaccine diseases including mucosal approaches and therapeutic vaccines. Ideas related to adjuvant classification, adjuvant selection, and their possible influence on innate recognition via multiple toll-like receptors are also discussed.


  • Open Access

    Interaction of HLA‐DR and CD74 at the cell surface of antigen‐presenting cells by single particle image analysis

    by Ioannis Karakikes, Ian E. G. Morrison, Peter O'TOole, Gergana Metodieva, Cristina V. Navarrete, Jesus Gomez, Jose M. Miranda‐Sayago, Richard J. Cherry, Metodi Metodiev, Nelson Fernandez

    Major histocompatibility complex (MHC) class II‐associated antigen presentation involves an array of interacting molecules. CD74, the cell surface isoform of the MHC class II‐associated invariant chain, is one such molecule; its role remains poorly defined. To address this, we have employed a high‐resolution single‐particle imaging method for quantifying the colocalization of CD74 with human leukocyte antigen (HLA)‐DR molecules on human fibroblast cells known for their capacity to function as antigen‐presenting cells. We have also examined whether the colocalization induces internalization of HLA‐DR using HA 307‐319 , a “universal” peptide that binds specifically to the peptide‐binding groove of all HLA‐DR molecules, irrespective of their alleles. We have determined that 25 ± 1.3% of CD74 and 17 ± 0.3% of HLA‐DR are colocalized, and the association of CD74 with HLA‐DR and the internalization of HLA‐DR are both inhibited by HA 307‐319 . A similar inhibition of HLA‐DR internalization was observed in freshly isolated monocyte‐derived dendritic cells. A key role of CD74 is to translocate HLA‐DR molecules to early endosomes for reloading with peptides prior to recycling to the cell surface. We conclude that CD74 regulates the balance of peptide‐occupied and peptide‐free forms of MHC class II at the cell surface.—Karakikes, I., Morrison, I. E. G., O'Toole, P., Metodieva, G., Navarrete, C. V., Gomez, J., Miranda‐Sayago, J. M., Cherry, R. J., Metodiev, M., Fernandez, N. Interaction of HLA‐DR and CD74 at the cell surface of antigen‐presenting cells by single‐particle image analysis. FASEB J. 26, 4886–4896 (2012). www.fasebj.org


  • Key Cellular Components and Interactive Histocompatibility Molecules Regulating Tolerance to the Fetal Allograft

    by Patrick S. Spencer, Soukaina M. Hakam, Phillipe P. Laissue, Asma Jabeen, Pallavi Jain, Soren Hayrabedyan, Krassimira Todorova, Alyssa Blanch, James M.W.R. McElhinney, Niwedhie Muhandiram, et al.